Progress in Biomaterials' 2026 Journal Metrics Score is 0.0, ranking Q4 in Biomedical Engineering and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 6.45.
Not available — there are not enough recent PubMed records with both received and accepted dates.
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
9 of 71 works · same type, year & subfield
1 works · same type, year & subfield
At field-year expectation
of 2,298 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.00, so its typical recent paper is in line with its field benchmark.
12.7% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2014–2023
71 OpenAlex works · 2021–2024
OpenAlex topics show the research communities this journal serves.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Biomedical Engineering | Q4 |
| Biomaterials | Q4 |
| Pharmaceutical Science | Q4 |
A lower-cited Q4 journal by citation data
By citation data, Progress in Biomaterials is in the lowest quartile in Biomedical Engineering and 2 other subfields and ranks #1,159 of 1,169 Materials Science journals by Journal Metrics Score (top 100%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Progress in Biomaterials' 2026 Journal Metrics Score is 0.0. OpenAlex lists an indicative article processing charge of $3,090 USD. OpenAlex classifies its papers in subfields including Biomedical Engineering, Biomaterials, and Pharmaceutical Science, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Progress in Biomaterials' papers in subfields including Biomedical Engineering, Biomaterials, and Pharmaceutical Science. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Progress in Biomaterials homepage ↗Use the submit link in Progress in Biomaterials' author guidelines; Springer Nature runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.
OpenAlex lists an indicative article processing charge of $3,090 USD. Check the current fee, waivers, and any institutional agreement on the journal website.
Progress in Biomaterials does not publish an acceptance rate.
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversBy citation data, Progress in Biomaterials is in the lowest quartile in Biomedical Engineering and 2 other subfields and ranks #1,159 of 1,169 Materials Science journals by Journal Metrics Score (top 100%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Progress in Biomaterials' 2026 Journal Metrics Score is 0.0. OpenAlex lists an indicative article processing charge of $3,090 USD. OpenAlex classifies its papers in subfields including Biomedical Engineering, Biomaterials, and Pharmaceutical Science, so check that your topic fits its scope.
Progress in Biomaterials' 2026 Journal Metrics Score is 0.0, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Progress in Biomaterials or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Progress in Biomaterials' quartile and score with similar journals, or ask the editorial office.
Progress in Biomaterials' best quartile is Q4. By OpenAlex subfield: Q4 in Biomedical Engineering; Q4 in Biomaterials; Q4 in Pharmaceutical Science. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Progress in Biomaterials will not match this score exactly. Compare journals using one source at a time.
OpenAlex lists an indicative article processing charge of $3,090 USD for Progress in Biomaterials. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include International Journal of Polymeric Materials and Polymeric Biomaterials, Journal of Biomedical Materials Research Part A, Biomaterials Advances, and Biomedical Materials. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Submit online through the link in Progress in Biomaterials' author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.